SCHEMBL18591884

SCHEMBL18591884

Cc1sc(NC(=O)C(N)CC(=O)OC(C)(C)C)c(C(=O)c2ccc(Br)cc2)c1C

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 10/20 0.44
▸ MAPT P10636 9/20 0.44
▸ HPGD P15428 8/20 0.44
▸ LMNA P02545 4/20 0.44
▸ PLA2G1B P04054 1/20 0.44
▸ MAPK1 P28482 1/20 0.44
▸ ATG4B Q9Y4P1 1/20 0.44
▸ GRIN2C Q14957 2/20 0.43
▸ SMN1; SMN2 Q16637 2/20 0.41
▸ HTT P42858 1/20 0.41
▸ NPSR1 Q6W5P4 1/20 0.41
▸ TDP1 Q9NUW8 1/20 0.41
▸ BRD4 O60885 1/20 0.41
▸ L3MBTL1 Q9Y468 1/20 0.41
▸ THRB P10828 1/20 0.39
▸ FLT3 P36888 1/20 0.39
▸ KDM4E B2RXH2 3/20 0.38
▸ NPC1 O15118 1/20 0.38
▸ RAB9A P51151 1/20 0.38
▸ CYP1A2 P05177 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL872773 0.91 BRD4 (0.49) ALDH1A1MAPTHPGDLMNAPLA2G1B
SCHEMBL872772 0.91 BRD4 (0.49) ALDH1A1MAPTHPGDLMNAPLA2G1B
SCHEMBL18551518 0.85 ALDH1A1 (0.52) ALDH1A1MAPTHPGDLMNAPLA2G1B
SCHEMBL18591849 0.84 LTA4H (0.48) ALDH1A1MAPTHPGDLMNAPLA2G1B
SCHEMBL31498654 0.83 MAPT (0.40) ALDH1A1MAPTHPGDLMNAPLA2G1B
SCHEMBL30411459 0.80 ALDH1A1 (0.53) ALDH1A1MAPTHPGDLMNAPLA2G1B
SCHEMBL30869908 0.79 BRD4 (0.38) ALDH1A1MAPTHPGDLMNAPLA2G1B
SCHEMBL25514096 0.79 ALDH1A1 (0.54) ALDH1A1MAPTHPGDLMNAPLA2G1B
SCHEMBL29730750 0.76 ALDH1A1 (0.48) ALDH1A1MAPTHPGDLMNAPLA2G1B
SCHEMBL24500208 0.76 ALDH1A1 (0.48) ALDH1A1MAPTHPGDLMNAPLA2G1B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230263893-A1 COMPOUNDS AND METHODS FOR THE TARGETED DEGRADATION OF BROMODOMAIN-CONTAINING PROTEINS ARVINAS OPERATIONS, INC. 2023-08-24 — — US disclosed
US-20170065719-A1 COMPOUNDS AND METHODS FOR THE TARGETED DEGRADATION OF BROMODOMAIN-CONTAINING PROTEINS ARVINAS OPERATIONS, INC. 2017-03-09 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230263893-A1 COMPOUNDS AND METHODS FOR THE TARGETED DEGRADATION OF BROMODOMAIN-CONTAINING PROTEINS BRPF3, STUB1, BRDT ALDH1A1 3365/4885MAPT 2849/4885HPGD 2457/4885
US-20170065719-A1 COMPOUNDS AND METHODS FOR THE TARGETED DEGRADATION OF BROMODOMAIN-CONTAINING PROTEINS BRPF3, STUB1, BRDT ALDH1A1 3365/4885MAPT 2849/4885HPGD 2457/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback